172 related articles for article (PubMed ID: 35764946)
21. Clinical performance of E2Fs 1-3 in kidney clear cell renal cancer, evidence from bioinformatics analysis.
Liang B; Zhao J; Wang X
Genes Cancer; 2017 May; 8(5-6):600-607. PubMed ID: 28740578
[TBL] [Abstract][Full Text] [Related]
22. WD Repeat Domain 77 Protein Regulates Translation of E2F1 and E2F3 mRNA.
Altayyar MA; Sheng X; Wang Z
Mol Cell Biol; 2020 Nov; 40(24):. PubMed ID: 33020149
[TBL] [Abstract][Full Text] [Related]
23. Mutant mouse models reveal the relative roles of E2F1 and E2F3 in vivo.
Cloud JE; Rogers C; Reza TL; Ziebold U; Stone JR; Picard MH; Caron AM; Bronson RT; Lees JA
Mol Cell Biol; 2002 Apr; 22(8):2663-72. PubMed ID: 11909960
[TBL] [Abstract][Full Text] [Related]
24. Combinatorial gene control involving E2F and E Box family members.
Giangrande PH; Zhu W; Rempel RE; Laakso N; Nevins JR
EMBO J; 2004 Mar; 23(6):1336-47. PubMed ID: 15014447
[TBL] [Abstract][Full Text] [Related]
25. microRNA‑202 suppresses MYCN expression under the control of E2F1 in the neuroblastoma cell line LAN‑5.
Li YG; He JH; Yu L; Hang ZP; Li W; Shun WH; Huang GX
Mol Med Rep; 2014 Feb; 9(2):541-6. PubMed ID: 24337320
[TBL] [Abstract][Full Text] [Related]
26. The Over-Expression of E2F3 Might Serve as Prognostic Marker for Neuroblastoma Patients with Stage 4S Disease.
Parodi S; Ognibene M; Haupt R; Pezzolo A
Diagnostics (Basel); 2020 May; 10(5):. PubMed ID: 32429447
[TBL] [Abstract][Full Text] [Related]
27. Predicting amplification of
Giwa A; Rossouw SC; Fatai A; Gamieldien J; Christoffels A; Bendou H
Future Oncol; 2021 Dec; 17(34):4769-4783. PubMed ID: 34751044
[TBL] [Abstract][Full Text] [Related]
28. Transcriptional repression of SKP2 is impaired in MYCN-amplified neuroblastoma.
Muth D; Ghazaryan S; Eckerle I; Beckett E; Pöhler C; Batzler J; Beisel C; Gogolin S; Fischer M; Henrich KO; Ehemann V; Gillespie P; Schwab M; Westermann F
Cancer Res; 2010 May; 70(9):3791-802. PubMed ID: 20424123
[TBL] [Abstract][Full Text] [Related]
29. Myc requires distinct E2F activities to induce S phase and apoptosis.
Leone G; Sears R; Huang E; Rempel R; Nuckolls F; Park CH; Giangrande P; Wu L; Saavedra HI; Field SJ; Thompson MA; Yang H; Fujiwara Y; Greenberg ME; Orkin S; Smith C; Nevins JR
Mol Cell; 2001 Jul; 8(1):105-13. PubMed ID: 11511364
[TBL] [Abstract][Full Text] [Related]
30. E2f1-3 switch from activators in progenitor cells to repressors in differentiating cells.
Chong JL; Wenzel PL; Sáenz-Robles MT; Nair V; Ferrey A; Hagan JP; Gomez YM; Sharma N; Chen HZ; Ouseph M; Wang SH; Trikha P; Culp B; Mezache L; Winton DJ; Sansom OJ; Chen D; Bremner R; Cantalupo PG; Robinson ML; Pipas JM; Leone G
Nature; 2009 Dec; 462(7275):930-4. PubMed ID: 20016602
[TBL] [Abstract][Full Text] [Related]
31. Cell proliferation in the absence of E2F1-3.
Wenzel PL; Chong JL; Sáenz-Robles MT; Ferrey A; Hagan JP; Gomez YM; Rajmohan R; Sharma N; Chen HZ; Pipas JM; Robinson ML; Leone G
Dev Biol; 2011 Mar; 351(1):35-45. PubMed ID: 21185283
[TBL] [Abstract][Full Text] [Related]
32. Dosage-dependent copy number gains in E2f1 and E2f3 drive hepatocellular carcinoma.
Kent LN; Bae S; Tsai SY; Tang X; Srivastava A; Koivisto C; Martin CK; Ridolfi E; Miller GC; Zorko SM; Plevris E; Hadjiyannis Y; Perez M; Nolan E; Kladney R; Westendorp B; de Bruin A; Fernandez S; Rosol TJ; Pohar KS; Pipas JM; Leone G
J Clin Invest; 2017 Mar; 127(3):830-842. PubMed ID: 28134624
[TBL] [Abstract][Full Text] [Related]
33. [Interaction of E2F/Rb family members with factor binding to co-repressor element on B-myb and E2F1 promoters].
Nakajima Y
Kokubyo Gakkai Zasshi; 1998 Jun; 65(2):172-88. PubMed ID: 9711036
[TBL] [Abstract][Full Text] [Related]
34. Multiple E2F-induced microRNAs prevent replicative stress in response to mitogenic signaling.
Bueno MJ; Gómez de Cedrón M; Laresgoiti U; Fernández-Piqueras J; Zubiaga AM; Malumbres M
Mol Cell Biol; 2010 Jun; 30(12):2983-95. PubMed ID: 20404092
[TBL] [Abstract][Full Text] [Related]
35. High Skp2 expression characterizes high-risk neuroblastomas independent of MYCN status.
Westermann F; Henrich KO; Wei JS; Lutz W; Fischer M; König R; Wiedemeyer R; Ehemann V; Brors B; Ernestus K; Leuschner I; Benner A; Khan J; Schwab M
Clin Cancer Res; 2007 Aug; 13(16):4695-703. PubMed ID: 17652624
[TBL] [Abstract][Full Text] [Related]
36. TP53 and TP53-associated genes are correlated with the prognosis of paediatric neuroblastoma.
Wang H; Wang X; Xu L; Zhang J
BMC Genom Data; 2022 Jun; 23(1):41. PubMed ID: 35655142
[TBL] [Abstract][Full Text] [Related]
37. E2F3/5/8 serve as potential prognostic biomarkers and new therapeutic direction for human bladder cancer.
Gan Z; Abudurexiti A; Hu X; Chen W; Zhang N; Sang W
Medicine (Baltimore); 2024 Jan; 103(2):e35722. PubMed ID: 38215110
[TBL] [Abstract][Full Text] [Related]
38. Distinct roles for E2F proteins in cell growth control and apoptosis.
DeGregori J; Leone G; Miron A; Jakoi L; Nevins JR
Proc Natl Acad Sci U S A; 1997 Jul; 94(14):7245-50. PubMed ID: 9207076
[TBL] [Abstract][Full Text] [Related]
39. Amplification of the E2F1 transcription factor gene in the HEL erythroleukemia cell line.
Saito M; Helin K; Valentine MB; Griffith BB; Willman CL; Harlow E; Look AT
Genomics; 1995 Jan; 25(1):130-8. PubMed ID: 7774910
[TBL] [Abstract][Full Text] [Related]
40. Tumorigenic proteins upregulated in the MYCN-amplified IMR-32 human neuroblastoma cells promote proliferation and migration.
Zaatiti H; Abdallah J; Nasr Z; Khazen G; Sandler A; Abou-Antoun TJ
Int J Oncol; 2018 Mar; 52(3):787-803. PubMed ID: 29328367
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
